跳至主要内容
临床试验/CTRI/2011/05/001731
CTRI/2011/05/001731招募中4 期

Evaluation of Resveratrol as a Dietary Supplement in Type 2 Diabetes Mellitus

Dr MJ Nanjan0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Male /female subjects with clinical diagnosis of Type 2 Diabetes Mellitus.
  • 2.Age group of 30-70 years
  • 3.Minimum 3 years of duration of disease.
  • 4.Patients with at least 6 months of ongoing oral antidiabetic treatment.
  • 5.Current ongoing medications like glibenclamide and metformin.
  • 6.Patients who have the ability to comply with procedure.
  • 7.Patients who are able to give consent for the study participation.

排除标准

  • 1.Pregnant or lactating women.
  • 2.Paediatric population with Juvenile diabetes mellitus.
  • 3.Type 1 diabetes Mellitus (IDDM).
  • 4.Patients with any other co-morbidity and/or contraindication that may interfere with the study result.
  • 5.Diabetic patients with significant hepatic, renal dysfunction and blood disorder.

研究者

发起方
Dr MJ Nanjan

相似试验